Supporting the

Neuroendocrine Cancer Community

New joint venture with AMEND to support Adrenocorticol Carcinoma (ACC) patients

Apr 17, 2013

We are delighted to have heard that Macmillan will be sponsoring a new service for ACC patients, to be run as a joint venture between AMEND and the NPF. Initial activities will include:

  • Produce updated patient information
  • Set up a website
  • Develop and distribute clinic leaflets and posters
  • Plan an ACC patient event

We will provide regular updates on this service.